$895 USD

Recorded Understanding Drug Valuation

Course Price: $895 USD
BIO Member Price: $795 USD
Course Run Time: 7 hours
Course Level: Level 2 - General
Completion Period: 3 month

This is the recorded Biopharma Revenue Forecasting course which has the same content, interactive exercises, and course materials that are given in the live version. You have 3 months to view this course.

Understanding Drug Valuation is a seven-hour tactical course invaluable for organizations that work in both preclinical/early clinical development all the way to mature biopharma. Develop knowledge of the core elements that influence revenue forecasting including pricing, competitive assessments, and epidemiology. Understand how the geography of the US, EU, Japan, China, and the rest of the world impacts revenue forecasting. Join our dynamic industry experts as they bring to life the ‘logical process’ of revenue forecasting using real-life case studies that participants work through together. The scope of this course includes:
• Geography: US, EU5, Japan, China, ROW
• Therapeutic area: oncology, specialty, rare diseases, gene therapy

Takeaways

1. Develop a broad understanding of how and why revenue forecasts are developed to
drive strategic decision-making and investing in the biopharma industry.
2. Become fluent in the core elements of revenue forecasting including epidemiology,
competitive assessments, market share assignment, duration of therapy, pricing, gross-to-
net margins, and annual price increases.
3. Understand how revenue forecasting varies across geographies and the considerations
that need to be accounted for.
4. Demonstrate the logical process (workstreams) that leads to effective, defensible
revenue forecasting and the interpretation of its findings.
5. Generate insights and actionable decisions from the forecasting process.

Certificate Requirements